SenesTech (NASDAQ:SNES – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($2.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($3.20) by $1.13, reports. The company had revenue of $0.48 million during the quarter. SenesTech had a negative net margin of 403.51% and a negative return on equity of 142.00%.
SenesTech Stock Performance
NASDAQ:SNES opened at $2.48 on Thursday. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.68 and a quick ratio of 3.49. SenesTech has a fifty-two week low of $1.90 and a fifty-two week high of $30.80. The business has a 50 day moving average price of $2.69 and a 200-day moving average price of $4.66.
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on shares of SenesTech in a research report on Saturday, November 9th. They set a “sell” rating for the company.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
See Also
- Five stocks we like better than SenesTech
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- About the Markup Calculator
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- Investing in Commodities: What Are They? How to Invest in Them
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
